Emcure Pharmaceuticals Ltd Q1 FY2026 consolidated net profit higher at Rs. 206.95 crores

Emcure Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 2104.233 crores during the period ended June 30, 2025 as compared to Rs. 2120.698 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 206.953 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 188.957 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 10.92 for the period ended June 30, 2025 as compared to Rs. 9.97 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 2104.233 crs	₹2120.698 crs	-0.78%
Net Profit	₹206.953 crs	₹188.957 crs	9.52%
EPS	₹10.92	₹9.97	9.53%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 2104.233 crores during the period ended June 30, 2025 as compared to Rs.1838.221 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.206.953 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.144.081 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.10.92 for the period ended June 30, 2025 as compared to Rs.7.95 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 2104.233 crs	₹1838.221 crs	14.47%
Net Profit	₹206.953 crs	₹144.081 crs	43.64%
EPS	₹10.92	₹7.95	37.36%

Shares of Emcure Pharmaceuticals Limited was last trading in BSE at Rs. 1398.80 as compared to the previous close of Rs. 1421.25. The total number of shares traded during the day was 11228 in over 970 trades.

The stock hit an intraday high of Rs. 1446.10 and intraday low of 1341.05. The net turnover during the day was Rs. 15885354.00.

Source : Equity Bulls

Keywords

EmcurePharmaceuticals Q1FY26 Q1FY2026 FY2026 ResultUpdate